CClinicalTrials.gg
RecruitingNCT04541849Updated May 17, 2024

Database for Predicting Clinical Outcomes of Critically Ill Patients

An observational study in Critical Illness, sponsored by National Taiwan University Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-05-17.

Sponsored by National Taiwan University Hospital · Observational

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as recruiting.
  • Started Sep 2020; still recruiting 6 years later.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
20,000
Ages
18 Years and older
Sex
All
01

Study summary

Australian and New Zealand Intensive Care Society (ANZICS) has built a Center of Outcome and Resource Evaluation (CORE) adult patients database (APD) of adult critically ill patients. ANZICS CORE APD has built an international collaboration of ICU database. National Taiwan University Hospital has joined this international collaboration and built the data according to the APD data dictionary with same value domain attributes and data element attributes. We retrospectively collected the data of patients discharged from the March 1, 2019 to June 30, 2022. Data of this database are permitted to study clinical problems and predict the clinical outcomes of these critically ill patients using statistical methods and machine learning techniques.

Read the detailed description

Data of this database are permitted to study the following clinical issues: including delirium, sepsis, acute kidney injury, acute respiratory distress syndrome, disseminated intravascular coagulation, multiple organ injuries, nutrition, survival status, number of days on ventilators, need for renal replacement therapy, length of stays in intensive care unit, length of stay in hospital, and other relevant clinical outcomes. It is also planned to analyze the clinical prognosis of special disease subgroups and establish a prediction model according to the type of patient's disease.

02

Conditions studied

  • Critical Illness

Browse trials for

03

In context

Critical Illness

1,881 studies on the registry are indexed under Critical Illness; 462 are open to participants now.

This study's planned enrollment of 20,000 is above the median of 130 across 867 observational studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Critically ill patients admitted to intensive care units

Inclusion criteria

  • Critically ill patients admitted to intensive care units

Exclusion criteria

Exclusion Criteria:

  • patients aged less than 18 years
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
20,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Critically ill patients

    Other: Critical Care

Interventions

  • OtherCritical Care

    Critical care in the intensive care units

06

What researchers measure

Primary outcomes

  1. 30-day mortality

    mortality status at 30 days after admission to intensive care unit

    Time frame: 30 days

Secondary outcomes

  1. Length of stay in intensive care unit

    number of days in intensive care unite

    Time frame: Time of discharge from intensive care unit, a median of 2-7 days

  2. Delirium

    Events of delirium within 48 hours after ICU admission

    Time frame: 48 hours

  3. Acute kidney Injury

    Events of acute kidney injury within 48 hours Time Frame:

    Time frame: 48 hours

  4. Length of stay in intensive care unit

    Number of days in intensive care unite

    Time frame: Time of discharge from hospital, more than 1 day

  5. Disseminated intravascular coagulation

    Events of disseminated intravascular coagulation within 48 hours after ICU admission

    Time frame: 48 hours

  6. Acute respiratory distress syndrome

    Events of acute respiratory distress syndrome within 48 hours after ICU admission

    Time frame: 48 hours

07

Study locations

1 of 1 sites recruiting
  • National Taiwan University Hospital
    Taipei, 100, Taiwan
    Recruiting
08

References and documents

Individual participant data

Plan to share: No — There is not a plan to make individual participant data available according to the regulation of research ethic committee of National Taiwan University Hospital.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 17, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04541849
Lead sponsor
National Taiwan University Hospital
Responsible party
Sponsor
First posted
Sep 9, 2020
Start date
Sep 10, 2020
Primary completion
Dec 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
May 17, 2024

Study contacts

Yu-Chang Yeh, MD, PhD
Contact
tonyyeh@ntuh.gov.tw
+886-9-10513711

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion